22. Fraser CL, Sarnacki P: Na
+
/K
+
ATPase pump
function in male rat brain synaptosomes is different
from that of females. Am J Physiol 257:E284, 1989.
23. Black RM: Disorders of serum sodium and serum
potassium.
In
Rippe JM, Irwin RS, Alpert JS, et al
(eds): Intensive Care Medicine. Boston, Little,
Brown, 1985.
24. Sarnaik AP, Meert K, Hackbarth R, et al: Manage-
ment of hyponatremic seizures in children with
hypertonic saline: A safe and effective strategy. Crit
Care Med 19:758, 1991.
25. Oh M, Carrol H: Disorders of sodium metabolism:
Hypernatremia and hyponatremia. Crit Care Med
20:94, 1992.
26. Perez GO, Oster JR, Robertson GL: Severe hyperna-
tremia with impaired thirst. Am J Nephrol 9:421,
1989.
27. Illner HP, Cunningham JN, Shires GT: Red blood
cell sodium content and permeability changes in
hemorrhagic shock. Am J Surg 143:349, 1982.
28. Coran AG: Perioperative care of the pediatric
patient. Surg Ann 23(Pt 1)31, 1991.
29. Brown MJ, Brown DL, Murphy MB: Hypokalemia
from
b
2 receptor stimulation by circulating epine
phrine. N Engl J Med 309:1414, 1983.
30. Vincent HH, Boomsma F, Man in’t Veld AJ, et al:
Effects of selective and nonselective beta agonists
on plasma potassium and norepinephrine. J Cardio-
vasc Pharmacol 6:107, 1984.
31. Papademetrious V, Fletcher R, Khatri IM, et al:
Diuretic-induced hypokalemia in uncomplicated
systemic hypertension: Effect of plasma potassium
correction on cardiac arrhythmias. Am J Cardiol
52:1017, 1983.
32. Papademetrious V, Burris J, Kukish SIM, et al: Effec-
tiveness of potassium chloride or triamterene in
thiazide hypokalemia. Arch Intern Med 145:1986,
1985.
33. DeFronzo RA: Intravenous potassium chloride
therapy. JAMA 245:2446, 1981.
34. Solomon RJ, Katz JD: Disturbances of potassium
homeostasis.
In
Stoelting RK (ed). Advances in
Anesthesia vol 3. Chicago, Year Book Medical
Publishers, 1986.
35. AllonM, Takeshian A, Shanklin N: Effect of insulin-
plus-glucose infusion with or without epinephrine
or fasting hyperkalemia. Kidney Int 43:212, 1993.
36. Holick MF, Krane SM, Potts JT: Calcium, phospho-
rus, and bone metabolism: Calcium-regulating hor-
mones.
In
Isselbacher KJ, Braunwald E, Wilson JD, et
al (eds): Harrison’s Principles of Internal Medicine,
13th ed. New York, McGraw-Hill, 1994, p 2139.
37. Vivien B, Langeron O, Morrell E, et al: Early hypo-
calcemia in severe trauma. Crit Care Med 33:1946,
2005.
38. Harris MNE, Crowther A, Jupp RA, et al: Magne-
sium and coronary revascularization. Br J Anesth
60:779, 1988.
39. Kamalanathan S, Vijayan A: Fluid and electrolyte
management.
In
Cooper DH, Krainik AJ, Lubner SJ,
et al (eds): The Washington Manual of Medical The
rapeutics, 32nd ed. Philadelphia, Lippincott
Williams & Wilkins, 2007, p 89.
40. James MFM: Clinical use of magnesium infusions
in anesthesia. Anesth Analg 74:129, 1992.
41. Cross HS, Debiec H, Peterlik M: Mechanism and
regulation of intestinal phosphate reabsorption.
Miner Electrolyte Metab 16:115, 1990.
42. Rhoades RA, Tanner GA: Medical Physiology.
Boston, Little, Brown, 1995.
43. Cohena J, Koganb A, Saharb G, et al: Hypo
phosphatemia following open heart surgery: Inci-
dence and consequences. Eur J Cardiothorac Surg
26:306, 2004.
44. Levinsky NG: Acidosis and alkalosis.
In
Isselbacher
KJ, Braunwald E, Wilson JD, et al (eds): Harrison’s
Principles of Internal Medicine, 13th ed. New York,
McGraw-Hill, 1994, p 255.
45. Drummond JC, Moore SS: The influence of dex-
trose administration on neurologic outcome after
temporary spinal cord ischemia in the rabbit. Anes-
thesiology 70:64, 1989.
46. Sieber FE, Traystman RJ: Special issues: Glucose
and the brain. Crit Care Med 20:104, 1992.
47. Stagnaro-Green A: Perioperative glucose control:
Does it really matter? Mt Sinai J Med 58:299,
1991.
48. McMurry JF Jr: Wound healing with diabetes melli-
tus: Better glucose control for better wound healing
in diabetes. Surg Clin North Am 64:769, 1984.
49. Welborn LG, McGill WA, Hannallah RS, et al: Perio-
perative blood glucose concentrations in pediatric
outpatients. Anesthesiology 65:543, 1986.
50. Welborn LG, McGill WA, Hannallah RS, et al:
Glucose concentrations for routine intravenous
infusion in pediatric outpatient surgery. Anesthe-
siology 67:427, 1987.
51. Degoute CS, Ray MJ, Manchon M, et al: Intraopera-
tive glucose infusion and blood lactate: Endocrine
and metabolic relationships during abdominal
aortic surgery. Anesthesiology 71:355, 1989.
52. The Carter Center of Emory University: Closing the
gap: The problem of diabetes mellitus in the United
States. Diabetes Care 8:391, 1985.
53. Nesmeth J: Type 2 diabetes in children and adoles-
cents. Pediatr Rev 105:671, 2000.
54. Foster DW: Endocrinology and metabolism.
In
Wilson JD, Braunwald E, Fauci AS, et al (eds):
Harrison’s Principles of Internal Medicine, 12th ed.
New York, McGraw-Hill, 1991, p 1743.
55. Engelgau MM, Herman WH, Smith PJ, et al: The
epidemiology of diabetes and pregnancy in the U.S.,
1988. Diabetes Care 18:1029, 1995.
56. Stewart WJ, McSweeney SM, Kellet MA, et al:
Increased risk of severe protamine reactions in
NPH insulin-dependent diabetics undergoing
cardiac catheterization. Circulation 70:788, 1984.
57. Humalog (insulin lispro) package insert. Indiana-
polis, IN, Eli Lilly, 2001.
58. Kucera ML, Graham JP: Insulin lispro, a new insulin
analog. Pharmacotherapy 18:526, 1998.
59. Dimarchi RD, Chance RE, Lon HB, et al: Prepara-
tion of an insulin with improved pharmacokinetics
relative to human insulin through consideration of
structure homology with insulin like growth factor
1. Horm Res 41(Suppl 2)93, 1994.
60. Howey DC, Bowsher RR, Brunelle RL, Woodworth
JR: Lys(B28) Pro(B29) human insulin: A rapidly
absorbed analog of human insulin. Diabetes 43:396,
1994.
61. Ciszak E, Beals JM, Frank BH, et al: Role of C-ter-
minal B-chain residues in insulin assembly: The
structure of Hexameric Lys(B28) Pro(B29) human
insulin. Structure 3:615, 1995.
62. Lantus (insulin glargine) package insert. Kansas
City, MO, Aventis Pharmaceuticals, April 2000.
63. Heinemann L, Linkeschova R, Rave K, et al: Time
action profile of the long-acting insulin analog
insulin glargine (HOE 901) in comparison with
those of NPH insulin and placebo. Diabetes Care
23:644, 2000.
64. Madsen H, Ditzel J: Changes in red blood cell
oxygen transport in diabetic pregnancy. Am J
Obstet Gynecol 143:421, 1982.
65. Kitamura A, Hoshino T: Patients with diabetic neu
ropathy are at risk of a greater intraoperative reduc-
tion in core temperature. Anesthesiology 92:1311,
2000.
66. Tsueda K, Huang KC, Dumond SW, et al: Cardiac
sympathetic tone in anaesthetized diabetics. Can J
Anaesth 38:20, 1991.
67. Kannel W, McGee D: Diabetes and cardiovascular
disease: The Framingham Study. JAMA 241:2035,
1979.
68. Haffner SM, Lehto S, Ronnemaa T, et al: Mortality
from coronary heart disease in subjects with type 2
diabetes and in nondiabetic subjects with and
without prior myocardial infarction. N Engl J Med
339:229, 1998.
69. Schaade DS: Surgery and diabetes. Med Clin North
Am 72:1531, 1988.
70. Gavin LA: Management of diabetes mellitus during
surgery. West J Med 151:525, 1989.
71. Reissel E, Orko R, Maunuksela E, et al: Predicta-
bility of difficult laryngoscopy in patients with
long-term diabetes mellitus. Anaesthesia 43:1024,
1990.
72. Hogan K, Rusty D, Springman SR: Difficult laryn-
goscopy and diabetes mellitus. Anesth Analg
67:1162, 1988.
73. Davidson MB, Schriger DC, Peters AL, et al: A cli-
nical approach for the diagnosis of diabetes melli-
tus: An analysis using glycosylated hemoglobin
levels. JAMA 276:1246, 1996.
74. Nathan DM: Hemoglobin A
1c
: Infatuation or the
real thing? N Engl J Med 323:1062, 1990.
75. American Hospital Formulary Service: Miscella-
neous Antidiabetic Agents. Bethesda, MD, ASHP,
2000, 68.20.92 3032-41.
76. Glucophage R (metformin) product information.
Princeton, NJ, Bristol-Myers-Squibb, October 2000.
77. Watson BG, Pay DA, Williamson M, et al: Practical
closed-loop insulin infusion. Life Support Syst
3(Suppl 1)519, 1985.
78. Hirsch IB, Magill JB, Cryer PE, et al: Perioperative
management of surgical patients with diabetes
mellitus. Anesthesiology 74:346, 1991.
79. Nutt LK, O’Neil RG: Effect of elevated glucose on
endothelin-induced store-operated and non-store-
operated calcium influx in renal mesangial cells. J
Am Soc Nephrol 11:1225, 2000.
80. Marhoffer W, Stein M, Maeser D, et al: Impairment
of PMN leukocyte function and metabolic control
of diabetes. Diabetes Care 15:256, 1992.
81. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A:
Continuous intravenous insulin infusion reduces
the incidence of deep sternal wound infection in
diabetic patients after cardiac surgical procedures.
Ann Thorac Surg 67:352, 1999.
82. Rassias AJ, Marrin CA, Arruda J, et al: Insulin infu-
sion improves neutrophil function in diabetic
cardiac surgery patients. Anesth Analg 88:1011,
1999.
83. Khaodhiar L, McCowen K, Bistrian B: Perioperative
hyperglycemia, infections and risk. Curr Opin Clin
Nutr Metab Care 2:79, 1999.
84. Boyle PJ, Schwartz NS, Shah SD, et al: Plasma
glucose concentrations at the onset of hypoglyce-
mic symptoms in patients with poorly controlled
diabetes and in nondiabetics. N Engl J Med
318:1487, 1988.
85. Wasserstrum N: Issues in fluid management during
labor: General considerations. Clin Obstet Gynecol
35:505, 1992.
86. Dutton R: Current concepts in hemorrhagic shock.
Anesthesiol Clin 25:23-34, 2007.
87. AlamHB, Rhee P: New developments in fluid resus-
citation. Surg Clin North Am 87:55, 2007.
88. Shoemaker WC, Appel PL, KramHB, et al: Prospec
tive trial of supranormal values of survivors as the
rapeutic goals in high risk surgical patients. Chest
94:1176, 1988.
1502
Control de la anestesia
III